Diclofenac sodium gel 1% + Placebo
Phase 3Completed 0 watching 0 views this week📈 Rising
77
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Muscle Soreness
Conditions
Muscle Soreness
Trial Timeline
Oct 1, 2014 → Dec 1, 2014
NCT ID
NCT02271854About Diclofenac sodium gel 1% + Placebo
Diclofenac sodium gel 1% + Placebo is a phase 3 stage product being developed by Novartis for Muscle Soreness. The current trial status is completed. This product is registered under clinical trial identifier NCT02271854. Target conditions include Muscle Soreness.
Hype Score Breakdown
Clinical
27
Activity
18
Company
10
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02271854 | Phase 3 | Completed |
Competing Products
20 competing products in Muscle Soreness